Ulticort Plus Lotion 0.01% + 0.045% is a topical combination therapy containing Halobetasol Propionate (0.01%) and Tazarotene (0.045%), formulated for the treatment of psoriasis and other corticosteroid-responsive dermatoses. This lotion combines the anti-inflammatory and immunosuppressive properties of a potent corticosteroid with the keratolytic and anti-proliferative effects of a topical retinoid, providing a dual mechanism to effectively manage psoriatic lesions.

Halobetasol Propionate, a super-potent corticosteroid, rapidly reduces redness, itching, and inflammation, while Tazarotene, a synthetic retinoid, normalizes abnormal keratinocyte differentiation and reduces scaling. The combination allows for faster lesion clearance, improved patient outcomes, and reduced long-term corticosteroid exposure compared to monotherapy.

Ulticort Plus Lotion is ideal for patients with moderate-to-severe plaque psoriasis or localized lesions requiring potent anti-inflammatory action along with keratinocyte regulation.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Topical corticosteroid and retinoid combination

Indications

Ulticort Plus Lotion 0.01% + 0.045% is indicated for:

• Plaque psoriasis: Reduces erythema, scaling, and plaque thickness

• Corticosteroid-responsive dermatoses: Effective in inflammatory skin conditions requiring potent steroid therapy

• Hyperproliferative skin conditions: Normalizes excessive keratinocyte turnover seen in psoriatic plaques

This lotion is particularly useful in patients who require both rapid anti-inflammatory action and long-term control of scaling and hyperkeratosis.

Pharmacology

Halobetasol Propionate:
A super-potent corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive effects. Halobetasol suppresses inflammatory mediator release, reduces vascular permeability, and inhibits immune cell infiltration in the affected skin.

Tazarotene:
A topical retinoid that selectively binds to retinoic acid receptors (RAR-β and RAR-γ). It regulates keratinocyte differentiation and proliferation, reduces epidermal hyperplasia, and decreases inflammation associated with psoriasis. Tazarotene also reduces scaling and promotes lesion resolution over time.

Combined Action:

• Halobetasol provides rapid symptomatic relief from redness, itching, and swelling

• Tazarotene addresses the underlying hyperproliferation of keratinocytes, improving long-term lesion control

• The combination allows for shorter corticosteroid exposure while maintaining efficacy

Mode of Action

• Halobetasol: Suppresses inflammation by modulating cytokine release and immune cell activity

• Tazarotene: Regulates keratinocyte proliferation and differentiation, reduces plaque thickness and scaling

• The synergistic effect results in faster lesion clearance and improved symptom management

Dosage and Administration

• Apply a thin layer of Ulticort Plus Lotion 1–2 times daily to affected areas, or as prescribed by a physician

• Gently rub until fully absorbed

• Use the lotion for the shortest duration required to control symptoms, usually up to 4 weeks

• Avoid applying on broken skin, mucous membranes, or sensitive areas

• Wash hands thoroughly after application

Special Considerations:

• Avoid excessive use to minimize risk of corticosteroid-related skin atrophy

• Avoid combining with other topical corticosteroids, keratolytics, or retinoids unless prescribed

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Hypersensitivity to Halobetasol, Tazarotene, or other components of the lotion

• Patients with viral, bacterial, or fungal infections of the skin unless treated appropriately

• Pregnancy and lactation unless clearly indicated and supervised by a physician

Side Effects

Common adverse effects may include:

• Mild burning, itching, or stinging at the application site

• Dryness, peeling, or redness

• Temporary irritation due to retinoid activity

Prolonged use may lead to:

• Skin atrophy, striae, or telangiectasia from corticosteroid

• Photosensitivity due to retinoid exposure

• Secondary infections if the skin barrier is compromised

Precautions and Warnings

• Avoid prolonged use on large areas to reduce systemic corticosteroid absorption

• Limit exposure to sunlight and ultraviolet therapy during treatment due to retinoid sensitivity

• Discontinue if severe irritation, rash, or allergic reactions occur

• Use with caution in elderly patients or those with thin or fragile skin

Pregnancy and Lactation

• Pregnancy: Tazarotene is teratogenic; use in pregnant women is contraindicated. Halobetasol should be used only if the potential benefit outweighs the risk.

• Lactation: Avoid use on large areas to prevent systemic absorption; consult a physician before application

Storage Conditions

• Store in a cool, dry place away from direct sunlight

• Keep out of reach of children.